PERRIGO Co plc
PRGONYSE
$10.72
↓ -3.9%Jul 17 close · end-of-day
Price
1Y↓ -57.0%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.5B
Enterprise Value
$5.1B
P/E
—
P/S
0.4
P/B
0.6
EV/EBITDA
—
PEG
—
FCF Yield
7.2%
Dividend Yield
10.8%
Revenue (TTM)
$4.2B
Net Income (TTM)
-$1.8B
Free Cash Flow (TTM)
$107.7M
Gross Margin
34.2%
Operating Margin
-36.9%
Net Margin
-43.5%
ROE
-72.7%
ROIC
-19.9%
Debt / Equity
1.5
Net Cash
-$3.6B
Return 1Y
-57.1%
Company profile
Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being. The company operates through two segments, Consumer Self-Care Americas and Consumer Self Care International. Its products include Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh and Burt's Bees brand names.
- CEO
- Murray S. Kessler
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 8,900
- Headquarters
- Michigan
- Website
- perrigo.com
Management & directors
- Khoury RobertoEVP and President of CSCI
- Winterman Matthew JohnEVP, Supply, Ops, Strategy
- Atkinson CharlesEVP, General Counsel & Sec.
- Ball DavidEVP & CBDO
- Bezzera Eduardo GuaritaEVP & Chief Financial Officer
- Lennox AbigailEVP and CSO
- Willis RobertEVP & CHRO
- Lockwood-Taylor PatrickCEO
Roles derived from SEC Form 4 filings.
Earnings
PRGO Q1 2026 Earnings
Period ends 2026-03-28
MetricActualYoY
Revenue$969.2M↓ -7.2%
Diluted EPS-$2.87↑ +5640.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $4.1B | $4.1B | $4.5B | $4.7B | $4.4B | $4.3B |
| Gross profit | $1.5B | $1.4B | $1.5B | $1.7B | $1.5B | $1.5B |
| Operating income | $265.2M | $410.4M | $78.9M | $151.9M | $112.9M | -$1.1B |
| Net income | -$162.6M | -$68.9M | -$140.6M | -$12.7M | -$171.8M | -$1.4B |
| Diluted EPS | -$1.19 | -$0.52 | -$1.04 | -$0.09 | -$1.25 | -$10.29 |
| Operating cash flow | $636.2M | $156.3M | $307.3M | $405.5M | $362.9M | $238.5M |
| Free cash flow | $465.8M | $4.2M | $210.9M | $303.8M | $244.6M | $145.1M |
| Gross margin | 36.6% | 34.2% | 32.7% | 36.1% | 35.3% | 35.1% |
| Operating margin | 6.5% | 9.9% | 1.8% | 3.3% | 2.6% | -26.4% |
| Net margin | -4.0% | -1.7% | -3.2% | -0.3% | -3.9% | -33.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.1B | $1.1B | $1.0B | $1.1B | $1.0B | $1.1B | $969.2M |
| Gross profit | $394.7M | $404.4M | $385.9M | $392.3M | $362.9M | $377.1M | $362.2M | $325.5M |
| Operating income | -$26.5M | $80.4M | $114.2M | $46.9M | $45.4M | $72.6M | -$1.3B | -$372.3M |
| Net income | -$108.4M | -$21.0M | -$44.4M | -$6.4M | -$8.4M | $7.5M | -$1.4B | -$398.6M |
| Diluted EPS | -$0.79 | -$0.15 | -$0.32 | -$0.05 | -$0.06 | $0.05 | -$10.23 | -$2.87 |
| Operating cash flow | $9.5M | $42.2M | $312.6M | -$64.5M | $75.9M | $51.7M | $175.4M | -$113.6M |
| Free cash flow | -$18.9M | $15.1M | $274.9M | -$90.0M | $56.7M | $29.8M | $148.6M | -$127.4M |
| Gross margin | 37.0% | 37.2% | 33.9% | 37.6% | 34.4% | 36.1% | 32.6% | 33.6% |
| Operating margin | -2.5% | 7.4% | 10.0% | 4.5% | 4.3% | 7.0% | -116.0% | -38.4% |
| Net margin | -10.2% | -1.9% | -3.9% | -0.6% | -0.8% | 0.7% | -127.8% | -41.1% |
Company news
Jun 30, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-08 | Winterman Matthew John· EVP, Supply, Ops, Strategy | Option exercise | 15,660 | $10.52 | $164,743.20 | filing |
| 2026-07-08 | Winterman Matthew John· EVP, Supply, Ops, Strategy | Tax withholding | 8,175 | $10.52 | $86,001.00 | filing |
| 2026-07-08 | Winterman Matthew John· EVP, Supply, Ops, Strategy | Option exercise | 1,843 | $10.52 | $19,388.36 | filing |
| 2026-07-08 | Winterman Matthew John· EVP, Supply, Ops, Strategy | Tax withholding | 963 | $10.52 | $10,130.76 | filing |
| 2026-07-08 | Khoury Roberto· EVP and President of CSCI | Option exercise | 737 | $10.52 | $7,753.24 | filing |
| 2026-07-08 | Khoury Roberto· EVP and President of CSCI | Tax withholding | 385 | $10.52 | $4,050.20 | filing |
| 2026-06-12 | Parker Geoffrey M. | Option exercise | 976 | $10.99 | $10,726.24 | filing |
| 2026-06-12 | Alford Bradley A | Option exercise | 976 | $10.99 | $10,726.24 | filing |
| 2026-06-12 | Alford Bradley A | Tax withholding | 469 | $10.99 | $5,154.31 | filing |
| 2026-06-12 | Parker Geoffrey M. | Tax withholding | 469 | $10.99 | $5,154.31 | filing |
| 2026-06-05 | Lockwood-Taylor Patrick | Option exercise | 25,230 | $10.83 | $273,240.90 | filing |
| 2026-06-05 | Lockwood-Taylor Patrick | Tax withholding | 12,906 | $10.83 | $139,771.98 | filing |
| 2026-06-05 | Bezzera Eduardo Guarita· EVP & Chief Financial Officer | Option exercise | 9,175 | $10.83 | $99,365.25 | filing |
| 2026-06-05 | Khoury Roberto· EVP and President of CSCI | Option exercise | 7,888 | $10.83 | $85,427.04 | filing |
| 2026-06-05 | Khoury Roberto· EVP and President of CSCI | Option exercise | 7,034 | $10.83 | $76,178.22 | filing |
| 2026-06-05 | Atkinson Charles· EVP, General Counsel & Sec. | Option exercise | 6,690 | $10.83 | $72,452.70 | filing |
| 2026-06-05 | Khoury Roberto· EVP and President of CSCI | Tax withholding | 4,118 | $10.83 | $44,597.94 | filing |
| 2026-06-05 | Lennox Abigail· EVP and CSO | Option exercise | 3,823 | $10.83 | $41,403.09 | filing |
| 2026-06-05 | Khoury Roberto· EVP and President of CSCI | Tax withholding | 3,672 | $10.83 | $39,767.76 | filing |
| 2026-06-05 | Willis Robert· EVP & CHRO | Option exercise | 3,441 | $10.83 | $37,266.03 | filing |
| 2026-06-05 | Khoury Roberto· EVP and President of CSCI | Option exercise | 2,980 | $10.83 | $32,273.40 | filing |
| 2026-06-05 | Ball David· EVP & CBDO | Option exercise | 2,867 | $10.83 | $31,049.61 | filing |
| 2026-06-05 | Bezzera Eduardo Guarita· EVP & Chief Financial Officer | Tax withholding | 2,235 | $10.83 | $24,205.05 | filing |
| 2026-06-05 | Lennox Abigail· EVP and CSO | Tax withholding | 1,996 | $10.83 | $21,616.68 | filing |
| 2026-06-05 | Atkinson Charles· EVP, General Counsel & Sec. | Tax withholding | 1,835 | $10.83 | $19,873.05 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.